Menu
Back to Journals » Journal of Hepatocellular Carcinoma » Volume 5
Original Research
Sorafenib plus tegafur–uracil (UFT) versus sorafenib as first line systemic treatment for patients with advanced stage HCC: a Phase II trial (ESLC01 study)
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 5,604 | Dovepress* | 5,059+ | 824 | 5,883 | |
| PubMed Central* | 545 | 129 | 674 | ||
| Totals | 5,604 | 953 | 6,557 | ||
| *Since 19 November 2018 | |||||
View citations on PubMed Central and Google Scholar